Schedule 13G ownership disclosure
Vallon Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 92023M101
Event date: 2022-05-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,050,232
- Percent of class
- Unavailable
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-062348
- Form type
- SC 13G
- Filer
- Lincoln Park Capital Fund, LLC
- CIK
- CIK 1592644
- Filed
- May 18, 2022
- Reporting period
- May 17, 2022
- Description
- Schedule 13G beneficial ownership